![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1489, 2005-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma
Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib beats standard therapy in relapsed multiple myeloma
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)